The 2026 data-driven guide to titanium dioxide (E171) in Australian supplements — EU ban context and TGA scrutiny
The short version
Titanium dioxide (TiO2, listed as E171 on supplement labels) is the white pigment that gives multivitamins, magnesium tablets, vitamin D capsules and probiotics their bright, uniform appearance. In May 2022, the European Union banned it as a food additive after the European Food Safety Authority (EFSA) concluded in 2021 that genotoxicity — DNA damage — could no longer be ruled out. Australia’s TGA has not banned it, which means E171 still appears in many supplements sold at Chemist Warehouse, Priceline and Coles Health.
This guide explains where E171 hides in the Australian supplement aisle, what the EU’s 2022 ban actually said, and how to identify E171-free brands without reading 30 labels in-store. For brand-by-brand ingredient scanning of any supplement on Australian shelves, use the Low Tox Gear Scanner — it flags E171 (alongside 230+ other rules) on every product page.
What changed in 2022 — and why Australia hasn’t followed
EFSA’s March 2021 reassessment concluded that titanium dioxide “can no longer be considered as safe when used as a food additive” — specifically because the nanoparticulate fraction of E171 cannot be excluded from causing genotoxicity (EFSA Journal, 2021). The European Commission moved to ban E171 in food in January 2022, with the ban taking effect across all EU member states by August 2022 (Commission Regulation (EU) 2022/63).
The UK’s Food Standards Agency reviewed the same data in 2022 and reached the opposite conclusion, leaving E171 permitted under UK food law. Australia’s Therapeutic Goods Administration (TGA) and Food Standards Australia New Zealand (FSANZ) similarly continue to permit E171 — FSANZ’s 2022 review concluded current dietary exposure poses no concern at the population level. The TGA permits E171 in registered and listed therapeutic goods, which includes most multivitamins and supplements.
The result: Australian shoppers see E171 in supplements that, if they were sold in supermarkets across Europe, would be reformulated or pulled. The split between regulators is the cleanest signal that this is an active scientific debate, not a settled question.
Where E171 hides in your supplement cabinet
E171 is almost never the active ingredient — it’s the cosmetic excipient that makes a capsule shell, tablet coating, or chewable look uniformly white. Common forms it appears in:
- Tablet coatings. Most coated multivitamin and supplement tablets use titanium dioxide as the opacifier in the film coat.
- Capsule shells. White, opaque gelatin and HPMC capsules typically contain E171. Transparent or clear-coloured capsules usually do not.
- Chewables and gummies. White-coloured chewable tablets and the white layer on layered gummies frequently use E171 alongside or in place of carmine / synthetic dyes.
- Powdered drink mixes. Less common, but some white-coloured greens or magnesium powders use E171 for visual consistency.
On labels, look for any of: titanium dioxide, E171, CI 77891, or colour 171. The presence of any of these means the product contains the additive.
What the peer-reviewed evidence actually shows
EFSA’s 2021 reassessment was triggered by accumulating evidence in three areas:
- Genotoxicity. In vitro studies showed E171 nanoparticles can induce DNA strand breaks and chromosomal aberrations in mammalian cells. EFSA noted that “the panel could not exclude a concern for genotoxicity” — the regulatory phrasing for “we can’t prove safety.”
- Gut absorption. Studies in animal models showed that orally ingested E171 nanoparticles can cross the intestinal barrier and accumulate in tissues (Pinget et al., 2019; Heringa et al., 2018).
- Pre-cancerous lesion promotion. Bettini et al. (2017, Scientific Reports) reported that rats orally exposed to E171 at typical human dietary levels developed colonic pre-neoplastic lesions and altered immune homeostasis in the gut.
FSANZ and the UK FSA pushed back, noting that the human dietary exposure data is imperfect and the rodent studies use higher doses than typical daily human intake. Both sides agree on the underlying mechanism — disagreement is about whether ordinary daily intake reaches a threshold of concern.
How to identify E171-free supplements in Australia
Three practical signals at the shelf:
- Read the “non-medicinal ingredients” or “excipients” section. By TGA labelling law, every excipient must be disclosed. E171 / titanium dioxide / CI 77891 must appear somewhere on the box or insert if it’s present.
- Prefer transparent or amber capsules over opaque white ones. The shell colour is the strongest single signal — clear and amber capsules almost never need E171 for opacity.
- Choose practitioner-only brands when possible. Practitioner brands (Thorne, Pure Encapsulations, Designs for Health, Seeking Health, Eagle, Bioceuticals' Clinical range) generally avoid E171 in newer formulations. Mass-market drugstore brands (Centrum, Swisse, Cenovis, Blackmores' standard line) are more likely to contain it in tablet coatings.
How the Low Tox Gear Scanner flags E171
Our chemical-rule database covers E171 under its three label aliases — “titanium dioxide,” “E171,” and “CI 77891”. The rule is scoped to food and supplement contexts (it doesn’t fire on cosmetic products like toothpaste, where E171 still has different regulatory standing). When the scanner finds it on a supplement page, it surfaces:
- The EU’s 2022 food-additive ban as primary citation
- The EFSA 2021 opinion as supporting evidence
- An amber severity flag for default users; escalated to red for users with Hashimoto’s, autoimmune conditions, or pregnancy
To check any supplement you’re considering, scan its barcode at scan.lowtoxgear.com, or browse the curated shortlist of clean supplements in Australia — currently 247 products that pass all our strict-clean filters, including no E171.
Best practice — what we recommend
Given the regulatory split and the available evidence, our position is:
- Active reformulation users should avoid E171 where the same supplement is available in an E171-free formulation from another brand. The cost is usually trivial (cents per dose at most), and the EFSA position represents the more conservative read of the evidence.
- Pregnancy and autoimmune conditions warrant stricter avoidance. The gut-permeability and immune-homeostasis findings are most relevant for these groups.
- Don’t replace a critical supplement with nothing just because the E171-free version is more expensive. The supplement’s active ingredient is almost always more important to your health than the excipient question.
Related guides on Low Tox Gear
- Clean supplements guide — broader framework for evaluating supplements beyond E171
- Capsule filler ingredients — every excipient that commonly appears in supplements
- Heavy metals in supplements — what TGA testing reveals about lead, cadmium, arsenic
- Supplement certifications guide — what TGA registered vs listed actually means
- TGA imported supplements warning — why iHerb imports aren’t the same as TGA-listed
Sources
- European Food Safety Authority (EFSA). Safety assessment of titanium dioxide (E171) as a food additive. EFSA Journal 2021;19(5):6585. doi:10.2903/j.efsa.2021.6585
- Commission Regulation (EU) 2022/63 of 14 January 2022 amending Annexes II and III to Regulation (EC) No 1333/2008 — withdrawal of E171 from the EU food additive list.
- Bettini S, Boutet-Robinet E, Cartier C, et al. Food-grade TiO2 impairs intestinal and systemic immune homeostasis, initiates preneoplastic lesions and promotes aberrant crypt development in the rat colon. Scientific Reports 2017;7:40373.
- Pinget G, Tan J, Janac B, et al. Impact of the food additive titanium dioxide (E171) on gut microbiota-host interaction. Frontiers in Nutrition 2019;6:57.
- FSANZ. Titanium dioxide (E171) in food — Australian dietary exposure assessment, 2022.
- UK Food Standards Agency. Risk assessment on titanium dioxide (E171), September 2022.
This guide is educational and does not constitute medical advice. Consult your healthcare provider before discontinuing any prescribed supplement. Last reviewed: May 2026.